Compounded tirzepatide: the whole picture, priced
Released: · Last reviewed:
Tirzepatide is a dual GIP and GLP-1 receptor agonist — it activates two incretin pathways, which is the pharmacological reason its trial averages lead the class. The FDA-approved brands are Mounjaro® (type 2 diabetes) and Zepbound® (chronic weight management and obstructive sleep apnea). "Compounded" tirzepatide is a different thing — a pharmacy preparation that is not FDA-approved — and this page treats it that way: evidence from the brand trials, prices from 50 tracked programs with a source and date on every one, and the 2026 legal reality without the sales gloss.
Quick answer
Compounded tirzepatide is a 503A pharmacy preparation of tirzepatide, legally available in 2026 only on an individual prescription with a documented clinical need — it is not FDA-approved and not equivalent to Mounjaro® or the other brands. Reported prices run $86–$399/month across 50 tracked programs; The lowest first-party-verified figure on file is $86/month from Collective ($69 medication plus a $199/year membership (about $17/mo), all-in); NexLife charged $115/month on its 12-month plan ($129 month-to-month, $0 membership) on that date; on November 20, 2026, Mondae charged less month to month with no membership, and Eden the same $129. Brand-trial evidence: SURMOUNT-1 reported ~20.9% mean weight loss over 72 weeks with brand tirzepatide 15 mg. Compounded versions have not been evaluated at trial scale. Talk to a licensed clinician.
Brand vs compounded: the distinction that governs everything
The brand products went through FDA review of manufacturing, sterility, stability, and dose accuracy. A compounded preparation is made by a licensed pharmacy for your prescription and skips that review by design — which is why concentration and formulation vary between pharmacies, and why the FDA has logged dosing errors tied to those differences. That does not make every compounded program illegitimate; it makes the pharmacy behind the program the single most important fact about it, which is why we run a pharmacy disclosure index.
What the trials actually showed
In SURMOUNT-1 (NEJM, 2022), brand tirzepatide at 15 mg produced roughly 20.9% mean weight loss over 72 weeks. In the SURMOUNT-5 head-to-head (2025), brand tirzepatide averaged about 20.2% versus 13.7% for brand semaglutide over 72 weeks — a manufacturer-funded, open-label trial. Those numbers describe the FDA-approved products in supervised trials; no compounded tirzepatide has published equivalent outcome data, and individual response varies enough that averages don't decide any single case.
What it costs — the live table
Sorted by lowest published figure; read the basis column before the price. Full state-level pages: Tirzepatide by state.
| Provider | Billing basis | Provenance | |
|---|---|---|---|
| WellMedr | $69/mo | “Starting at” figure during a Black Friday sale; shipped every 4 weeks; plan term not printed sale price term not stated | First-partywellmedr.com · 2026-11-20 |
| Collective | $86/mo all-in | $69 medication (month-to-month); calendar-month billing; flat at every dose; +$199/year membership (about $17/mo) = $86/mo all-in membership billed beside | First-partycollective.org · 2026-11-20 |
| PreventiveMD | $97/mo all-in | “As low as … all-in” on its longest plan; plan length and dose policy not stated in the page text longest plan | First-partypreventivemd.com · 2026-11-20 |
| Gala GLP-1 | $99/mo | annual plan billed once a year; the price depends on state, dose and plan and is shown before payment; no separate membership fee prepaid year | First-partygalaglp1.com · 2026-11-20 |
| Fridays | $99/mo | “As low as” price with a 75%-off code; the same page also prints $240 a month and $389 a month on an annual plan; membership included promotional rate conflicting figures | First-partyjoinfridays.com · 2026-11-20 |
| Mondae | $114/mo | 6-month plan paid up front ($684); $126 month-to-month, $124 on 3 months; no membership fee prepaid term | First-partymondae.com · 2026-11-20 |
| NexLife | $115/mo | 12-month plan ($129 month-to-month; $125 / $119 on 3- and 6-month plans); same price at every dose; $0 membership | First-partynexlife.us · 2026-11-06 |
| Embody | $119/mo | 12-mo plan; ($129 month-to-month); $0 membership prepaid · all sales final one-month sale price | First-partyjoinem.co · 2026-10-15 |
| SnagRx | $119/mo | pre-Black Friday sale price against a $349 list price; term not printed; no monthly membership promotional rate | First-partysnagrx.com · 2026-11-20 |
| Yucca Health | $119/mo | 12-month plan paid up front ($1,428); $139 month-to-month, $125 on a 6-month plan ($750); same price at every dose term prepaid | First-partyYucca help center · 2026-11-20 |
| NewMeMeds | $125/mo | 12-mo plan; ($149 month-to-month); payment basis not printed; flat at every dose; $0 membership promotional rate term basis not stated | First-partynewmemeds.com (site not resolving on 2026-11-20) · 2026-09-20 |
| Ozari Health | $125/mo | billed quarterly ($375 every 3 months); same price at every dose; membership not mentioned quarterly prepay | First-partyozarihealth.com · 2026-11-20 |
| CoreAge Rx | $129/mo | “starting at” rate, term not stated; no membership fee term not stated | First-partycoreagerx.com · 2026-11-20 |
| Eden | $129/mo | month-to-month; flat at every dose; no membership fee (“The price you see is the price you’ll keep”) | First-partyeden.health · 2026-11-20 |
| GobyMeds | $133/mo | 3-mo plan; ($299 month-to-month); rising to $200 by dose; $0 membership prepaid · all sales final | First-partygobymeds.com · 2026-11-20 |
| yourEra | $134/mo | 6-month plan ($804) at a Black Friday 25% discount the page says is kept on renewal; $186 month-to-month ($248 before the sale), $164 on 3 months; same price at every dose sale price prepaid term | First-partyyourera.com · 2026-11-20 |
| Lavender Sky Health | $139/mo | one-month starter supply; 8–10-week tier supplies from $195; priced by dose and pharmacy; no membership for compounded plans priced by dose | First-partylavenderskyhealth.com · 2026-11-20 |
| Telos RX | $139/mo | “as low as” rate, term not stated; flat at every dose; laboratory review included; $0 membership term not stated “as low as” rate | First-partytelosrx.com · 2026-11-20 |
| Sunlight | $139/mo | flat monthly rate under an “Early Black Friday” banner promotional rate | First-partysunlight.com · 2026-11-20 |
| Mochi Health | $139/mo all-in | $90 starting-dose medication + $49/month membership on a 12-month plan ($79 membership month to month = $169 all-in); medication priced by dose and billed separately priced by dose membership billed beside | First-partyjoinmochi.com · 2026-11-20 |
| Ondra Health | $142/mo | 12-month plan ($1,699); $219 month-to-month, $183 / $167 on 3 and 6 months; flat pricing across doses; $0 membership term prepaid | First-partyondra.health · 2026-11-20 |
| Sprout Health | $149/mo | 12-month plan billed $1,788 up front; otherwise $199 every 4 weeks (about $216 per true month); same price at any dose prepaid year | First-partyjoinsprouthealth.com · 2026-11-20 |
| Fifty 410 | $149.50/mo | 8-week program, $299 total (about $149.50 per 4 weeks; not offered in every state); 4-week program $199 4-week cycles | First-partyfifty410.com · 2026-11-20 |
| He & She MD | $159/mo | 12-mo plan; ($339 month-to-month); calendar-month billing; flat at every dose; $0 membership term prepaid | First-partyheandshemd.com (site not resolving on 2026-11-20) · 2026-10-15 |
| TMates | $167/mo | 12-mo plan; ($297 month-to-month) | Reportedrangeyourself.com · 2026-08-21 |
| Bodybuilding Health+ | $175/mo | 6-mo plan; ($209 month-to-month); payment basis not printed; $0 membership term basis not stated | First-partybbhealthplus.com · 2026-11-20 |
| bmiMD | $179/mo | 12-mo plan; ($249 month-to-month); calendar-month billing; flat at every dose; $0 membership promotional rate term prepaid · all sales final | First-partybmimd.com · 2026-09-17 |
| Ivim Health | $192/mo all-in | “starting at” $117 medication + $75/month program fee = $192/mo all-in program fee billed beside | First-partyivimhealth.com · 2026-11-20 |
| HealthRX | $199/mo | month-to-month after a $39 first month; prepaid tiers no longer printed; no membership fee intro steps up | First-partyhealthrx.com · 2026-11-20 |
| Alloy | $199/mo all-in | $100 medication (“as low as” rate, term not stated); +$99/month membership = $199/mo all-in term not stated membership billed beside | First-partymyalloy.com · 2026-11-20 |
| Curex | $199/mo | “From” price including prescription and medication; no membership fee term not stated | First-partygetcurex.com · 2026-11-20 |
| Fella Health | $199/mo | 12-mo plan | Reportedfellahealth.com · 2026-08-25 |
| Found | $199/mo | 12-month plan, per 28-day cycle (about $216 per true month); $339 / $269 / $249 on the 1-, 3- and 6-month plans; $199 first month on the month-to-month plan; care and medication included 4-week cycles | First-partyjoinfound.com · 2026-11-20 |
| MadeMed | $199/mo | “From” price (struck-through $249); tirzepatide with pyridoxine (vitamin B6); term not stated term not stated | First-partymademed.com · 2026-11-20 |
| Midi Health | $210/mo | dose-priced “Dual-Action GLP-1/GIP” injection: $210 at 1.25–2.5 mg up to $434 at 13.75–15 mg; billing period not printed; no membership fee; shipping and supplies included priced by dose basis unclear | First-partyjoinmidi.com · 2026-11-20 |
| TelePeptide | $214/mo | 12-mo plan; ($249 month-to-month); calendar-month billing; $0 membership term prepaid | First-partytelepeptide.org · 2026-11-20 |
| Strut Health | $219/mo | monthly auto-refill; one flat price for every strength; consultations and shipping included | First-partystruthealth.com · 2026-11-20 |
| Peak Wellness | $232/mo | 6-month plan paid up front ($1,392); $349 month-to-month after a $279 first month, $279 on 3 months; same price at every dose term prepaid | First-partygo.trypeak.com · 2026-11-20 |
| ShedRx | $239/mo | “as low as” rate, term not stated; $0 membership term not stated | First-partytryshed.com · 2026-11-20 |
| Pallas Health | $239/mo | annual-plan average; otherwise $179 first month, then $299 every 4 weeks (about $325 per true month); final once prescribed annual plan | First-partypallashealth.co · 2026-11-20 |
| MyDrHank | $240/mo | “From” price; plan length and membership not stated basis unclear | First-partymydrhank.com · 2026-11-20 |
| MEDVi | $279/mo | sale figure in the page’s price script (prices render as unfilled placeholders); $299–$399 month-to-month in the same script sale price basis unclear | Reportedglp1.medvi.org · 2026-10-15 |
| Enhance MD | $280/mo | 12-mo plan; ($329 month-to-month); flat at every dose; $0 membership term prepaid | First-partyenhance.md · 2026-11-20 |
| Luvo Health | $291/mo | 12-mo plan; ($339 per 4-week cycle) 13 four-week cycles | Reportedrangeyourself.com · 2026-08-08 |
| OrderlyMeds | $299/mo | month-to-month; same price every month; new customers pay $299 for the first 2 months intro offer | First-partyorderlymeds.com · 2026-11-20 |
| Zappy Health | $299/mo | 6-month plan ($1,794); $349 month-to-month, $329 on 3 months; same price at every dose; no membership fee; a 2.5–5 mg microdose plan is priced separately term prepaid | First-partyzappyhealth.com · 2026-11-20 |
| Noom Med | $299/mo | after a $149 first 4 weeks; billed $897 every 12 weeks; clinical care and the digital program included quarterly billing | First-partynoom.com · 2026-11-20 |
| Direct Meds | $399/mo | compounded tirzepatide injection, all-in (medication, supplies, physician review, shipping); no membership fee | First-partydirectmeds.com · 2026-11-20 |
| Remedy Meds | $399/mo | month-to-month; calendar-month billing; flat at every dose | First-partyremedymeds.com · 2026-11-20 |
| Willow | $399/mo | month-to-month; flat at every dose; $0 membership | First-partystartwillow.com · 2026-11-20 |
| Zealthy | $449/mo | monthly bundle after a $349 first month | First-partygetzealthy.com · 2026-11-20 |
| Levity | $1,249/mo | month-to-month brand-only — confirm confirm at enrollment | Reportedweightlossrankings.org · 2026-08 |
Cost planning across the titration ladder: the tirzepatide dose & cost tool. Every figure's field-level detail is in the open dataset.
Legality in 2026, in four sentences
The FDA declared the shortages resolved (tirzepatide December 2024, semaglutide February 21, 2025), which ended shortage-era mass compounding; 503B facilities wound down by March 19, 2025. What remains is 503A patient-specific compounding with a documented clinical reason the approved products won't serve that patient. Price is not such a reason, and "personalized dosing" is the contested territory Eli Lilly and Novo Nordisk are litigating. State pharmacy boards layer their own rules on top — our state pages track what differs where.
Formats: injectable first
The evidence base is subcutaneous injection. Oral drops, lozenges, and "ODT" formats are sold at confident prices with no published human absorption data for these peptides by the oral-mucosal route from any seller — the full argument is in our evidence review. Price the injectable first; make any alternative-route seller show absorption data before paying a premium.
Frequently asked questions
What is compounded tirzepatide?
How much does compounded tirzepatide cost in 2026?
Is compounded tirzepatide legal in 2026?
Compounded tirzepatide vs semaglutide — which should I take?
Keep going